Quarterly report · Q2
3154.TEDINET S100Q408
Period2022-07-01 → 2022-12-31
Filed2023-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amended by S100RJV7 (2023-08-14).
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥115.8bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥221.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥109.7bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥859m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥99.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥95.3bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.9bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.5bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.2bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥3.3bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥3.9bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.5bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥291m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥3.5bn | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.2bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.0bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥39.19 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.8 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.37 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.93 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.07 | 2022-07-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥65.34 | 2021-07-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥81,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥81,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥3.7bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥113.1bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥113.1bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥81,000 |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥197m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2022-12-31 | ¥115.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2022-12-31 | ¥115.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥81,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2022-12-31 | ¥4.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥3.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥107.0bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥107.0bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥4.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥278m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-12-31 | ¥109.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-12-31 | ¥109.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-12-31 | ¥5.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 553
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses sga | Prior1YTDDuration | 37460000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 40691000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 21350000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 25000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 243860000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 272394000 | JPY |
| Legal welfare expenses sga | Prior1YTDDuration | 942756000 | JPY |
| Legal welfare expenses sga | CurrentYTDDuration | 1027197000 | JPY |
| Depreciation sga | Prior1YTDDuration | 259428000 | JPY |
| Depreciation sga | CurrentYTDDuration | 536712000 | JPY |
| Rent expenses sga | Prior1YTDDuration | 960401000 | JPY |
| Rent expenses sga | CurrentYTDDuration | 1072916000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration | 1044085000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration | 1187166000 | JPY |
| Other sga | Prior1YTDDuration | 2212444000 | JPY |
| Other sga | CurrentYTDDuration | 2524493000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 11789731000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 13324307000 | JPY |
| Operating income | Prior1YTDDuration | 1675450000 | JPY |
| Operating income | CurrentYTDDuration | 1097341000 | JPY |
| Interest income noi | Prior1YTDDuration | 2145000 | JPY |
| Interest income noi | CurrentYTDDuration | 952000 | JPY |
| Dividends income noi | Prior1YTDDuration | 28392000 | JPY |
| Dividends income noi | CurrentYTDDuration | 51170000 | JPY |
| Purchase discounts noi | Prior1YTDDuration | 164358000 | JPY |
| Purchase discounts noi | CurrentYTDDuration | 155655000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 16672000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | - | JPY |
| Reversal of provision for loss on guarantees noi | Prior1YTDDuration | 8208000 | JPY |
| Reversal of provision for loss on guarantees noi | CurrentYTDDuration | 4174000 | JPY |
| Other noi | Prior1YTDDuration | 68366000 | JPY |
| Other noi | CurrentYTDDuration | 93634000 | JPY |
| Non operating income | Prior1YTDDuration | 288144000 | JPY |
| Non operating income | CurrentYTDDuration | 305588000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 31399000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 43295000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | - | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 7659000 | JPY |
| Other noe | Prior1YTDDuration | 3962000 | JPY |
| Other noe | CurrentYTDDuration | 9865000 | JPY |
| Non operating expenses | Prior1YTDDuration | 35362000 | JPY |
| Non operating expenses | CurrentYTDDuration | 60819000 | JPY |
| Ordinary income | Prior1YTDDuration | 1928232000 | JPY |
| Ordinary income | CurrentYTDDuration | 1342110000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 3905000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 4848000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | - | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 108328000 | JPY |
| Extraordinary income | Prior1YTDDuration | 3905000 | JPY |
| Extraordinary income | CurrentYTDDuration | 113177000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |